论文信息 - Development and Validation of UV-Visible Spectrophotometric Method for Estimation of Tacrolimus in Bulk and Pharmaceutical Nanoparticles

Development and Validation of UV-Visible Spectrophotometric Method for Estimation of Tacrolimus in Bulk and Pharmaceutical Nanoparticles

A UV-visible spectrophotometric method for quantifying tacrolimus in nanoparticles has been developed and validated, and it is accurate, simple, reproducible, and affordable. For drug analysis, optimal conditions have been identified. 291 nm was discovered to be the maximum wavelength (max). In the range of 0.2-1.8 mg/ml, the response was linear (r2 = 0.9989). The intra- and inter-day relative standard deviations for precision studies were found to be less than 2%, indicating that the procedure is precise.

[1] S. G. Cardoso,et al. Determination of tacrolimus in pharmaceutical formulations by validated spectrophotometric methods , 2009 .

[2] R. Grand,et al. Tacrolimus‐associated eosinophilic gastroenterocolitis in pediatric liver transplant recipients: Role of potential food allergies in pathogenesis , 2006, Pediatric transplantation.

[3] G. Amidon,et al. Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. , 2002, Journal of pharmaceutical sciences.

[4] J. Nadal,et al. Validation of Analytical Methods for Tacrolimus Determination in Poly(ε-caprolactone) Nanocapsules and Identification of Drug Degradation Products. , 2021, Journal of nanoscience and nanotechnology.

[5] Dipti,et al. FORMULATION AND EVALUATION OF TACROLIMUS LOADED LIQUID CRYSTALLINE NANOPARTICLES , 2018 .

[6] C. Staatz,et al. Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation , 2004, Clinical pharmacokinetics.